Company / Operating Cash Flow
FENNEC PHARMACEUTICALS INC. Operating Cash Flow History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$27.0M
FY2025
5-year range
-$18.1M / $27.0M
FY2021-FY2025
Trend
+257.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow changed +257% YoY in FY2025, a notable deviation from the 9-year average annual change of -4%.
Based on SEC 10-K filings.
$27M in FY2025.
Improved from -$18M to $27M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 257.4% year-over-year.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.0M | +257.4% |
| FY2024 | -$17.1M | +5.1% |
| FY2023 | -$18.1M | -15.8% |
| FY2021 | -$15.6M | -99.3% |
| FY2019 | -$7.8M | -114.9% |
| FY2018 | -$3.6M | -71.4% |
| FY2017 | -$2.1M | -14.1% |
| FY2016 | -$1.9M | -9.6% |
| FY2015 | -$1.7M | +23.1% |
| FY2014 | -$2.2M | +26.2% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026